Clinical Research on two continents
The PelvicToner has been the subject of clinical trials in both the US and the UK. Both trials concluded that the PelvicToner offered an effective treatment for health conditions caused by pelvic floor weakness.
US trial
The US trial set out to establish the potential of the PelvicToner to cure the symptoms of urinary stress incontinence.
The trial showed that, on average, the resting strength increased by nearly 30%. The most stunning result was that the average active (Kegel) squeeze of the participants increased by nearly 40%.
Both these findings confirm the benefit of resistance exercise and explain why users of the PelvicToner have much better bladder control and generally feel more confident and in control of functions dependent upon pelvic floor muscle tone.
British clinical trial
The UK clinical trial set out with one objective, to establish whether the PelvicToner was as effective as the best NHS treatment of the day.
The study concluded that it is.
Self-treatment in the privacy of your own home using a PelvicToner was shown to be as effective a treatment for a weak pelvic floor as a three month course of pelvic floor muscle training supervised by a specialist physiotherapist costing £100s.